Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Over-the-Counter

Spirit Pharmaceuticals, LLC: Ibuprofen 200 mg Tablets Recalled for Manufacturing Deviations

Agency Publication Date: March 8, 2018
Share:
Sign in to monitor this recall

Summary

Spirit Pharmaceuticals, LLC is recalling 144 bottles of Ibuprofen Tablets USP (200 mg) sold in 100-count bottles. This over-the-counter pain reliever and fever reducer is being recalled because it was manufactured under conditions that deviated from Current Good Manufacturing Practice (CGMP) standards, which were identified following a previous recall. Consumers should contact their healthcare provider or pharmacist regarding the use of this medication and for instructions on returning any remaining product.

Risk

Manufacturing deviations mean the safety, quality, and purity of the medication cannot be guaranteed. While no specific injuries or adverse events have been reported for this lot, drugs produced outside of established safety standards may not contain the correct amount of active ingredient or could contain unintended impurities.

What You Should Do

  1. Check your medicine cabinet for 100-count bottles of Ibuprofen Tablets USP, 200 mg, distributed by Spirit Pharmaceuticals, LLC.
  2. Verify the bottle for NDC number 68210-0800-1 and specifically look for Lot Number HJ6138 printed on the packaging.
  3. If you have a bottle from Lot HJ6138, stop using the medication immediately.
  4. Contact your healthcare provider or pharmacist for guidance on alternative medications and to discuss any health concerns.
  5. Return any unused product to the place of purchase for a refund and contact Spirit Pharmaceuticals at the address in Ronkonkoma, NY, for further instructions.
  6. For additional questions or to report a problem, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Manufacturer-initiated drug recall refund and guidance

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Ibuprofen Tablets USP, 200 mg (100-count bottles)
Model:
NDC 68210-0800-1
Lot Numbers:
HJ6138

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 79361
Status: Resolved
Manufacturer: Spirit Pharmaceuticals, LLC
Sold By: Retail pharmacies
Manufactured In: United States
Units Affected: 144 bottles
Distributed To: New York

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.